Use of bayesian analysis to design of clinical trials with one treatment

DOI10.1080/03610928408828787MaRDI QIDQ3345648zbMATH OpenOpenAlexFDO

Authors Jorge Alberto Achcar

Publication date 1984

Published in Communications in Statistics: Theory and Methods (Search for Journal in Brave)

Full work available at URL https://doi.org/10.1080/03610928408828787

zbMATH Keywords

clinical trialsWeibull distributionposterior distributionmedian survival timeright censorshipfollow-up periodsnumber of patients

Mathematics Subject Classification ID

Bayesian inference (62F15) Reliability and life testing (62N05) Applications of statistics to biology and medical sciences; meta analysis (62P10)

Recommendations

• A Bayesian adaptive design for two-stage clinical trials with survival data
• A Bayesian Approach to the Design of Phase II Clinical Trials
• Designing Follow-Up Times
• A Bayesian approach to Weibull survival models -- application to a cancer clinical trial
• Bayesian interim analysis of censored exponential observations

Cited in

(3)

• Designing Follow-Up Times
• Robust Bayesian analysis of Weibull failure model
• Bayesian approach to determine the number of subsequent users of a new treatment

This page was built for publication: Use of bayesian analysis to design of clinical trials with one treatment

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3345648)